The present guideline update aims to use the best available evidence on the treatment of DS-TB in order to inform policy decisions made in this technical area by national TB control programme managers, national policy-makers and medical practitioners in a variety of geographical, economic and social settings.

The objectives of the updated Guidelines are:

1) to provide updated recommendations based on newly emerged evidence on the treatment of drug-susceptible TB; and

2) to provide a summary of changes in the new guidelines together with all existing and valid WHO recommendations on the treatment of DS-TB.

Book navigation